Bank of New York Mellon
IRMD icon

Bank of New York Mellon’s iRadimed IRMD Stock Holding History

Bank of New York Mellon’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.25M Sell
75,885
-3,992
-5% -$364K ﹤0.01% 2208
2026
Q1 		$7.69M Sell
79,877
-5,654
-7% -$565K ﹤0.01% 2065
2025
Q4 		$8.32M Sell
85,531
-17,701
-17% -$1.52M ﹤0.01% 2036
2025
Q3 		$7.35M Sell
103,232
-555
-0.5% -$37K ﹤0.01% 2104
2025
Q2 		$6.21M Buy
103,787
+2,122
+2% +$116K ﹤0.01% 2153
2025
Q1 		$5.34M Buy
101,665
+1,557
+2% +$87.5K ﹤0.01% 2188
2024
Q4 		$5.51M Buy
100,108
+48,534
+94% +$2.55M ﹤0.01% 2242
2024
Q3 		$2.59M Sell
51,574
-6,397
-11% -$295K ﹤0.01% 2624
2024
Q2 		$2.55M Buy
57,971
+4,363
+8% +$186K ﹤0.01% 2662
2024
Q1 		$2.36M Sell
53,608
-2,423
-4% -$107K ﹤0.01% 2679
2023
Q4 		$2.66M Buy
56,031
+491
+0.9% +$20.6K ﹤0.01% 2685
2023
Q3 		$2.46M Buy
55,540
+1,389
+3% +$64.5K ﹤0.01% 2689
2023
Q2 		$2.59M Buy
54,151
+1,146
+2% +$51.7K ﹤0.01% 2690
2023
Q1 		$2.09M Sell
53,005
-1,522
-3% -$55.3K ﹤0.01% 2787
2022
Q4 		$1.54M Sell
54,527
-1,472
-3% -$42.1K ﹤0.01% 2987
2022
Q3 		$1.68M Buy
55,999
+2,124
+4% +$74K ﹤0.01% 2943
2022
Q2 		$1.83M Buy
53,875
+191
+0.4% +$6.85K ﹤0.01% 2887
2022
Q1 		$2.41M Sell
53,684
-7,581
-12% -$351K ﹤0.01% 2828
2021
Q4 		$2.83M Buy
61,265
+165
+0.3% +$6.66K ﹤0.01% 2779
2021
Q3 		$2.05M Buy
61,100
+2,172
+4% +$73.9K ﹤0.01% 2957
2021
Q2 		$1.73M Sell
58,928
-76
-0.1% -$2.09K ﹤0.01% 3088
2021
Q1 		$1.52M Sell
59,004
-125
-0.2% -$2.99K ﹤0.01% 3083
2020
Q4 		$1.35M Buy
59,129
+3,097
+6% +$71.6K ﹤0.01% 3078
2020
Q3 		$1.2M Sell
56,032
-273
-0.5% -$6.13K ﹤0.01% 3010
2020
Q2 		$1.31M Buy
56,305
+1,236
+2% +$26.5K ﹤0.01% 2949
2020
Q1 		$1.18M Sell
55,069
-823
-1% -$19.6K ﹤0.01% 2861
2019
Q4 		$1.31M Buy
55,892
+3,869
+7% +$90.4K ﹤0.01% 3093
2019
Q3 		$1.09M Buy
52,023
+3,532
+7% +$72.1K ﹤0.01% 3130
2019
Q2 		$991K Buy
48,491
+11,888
+32% +$280K ﹤0.01% 3213
2019
Q1 		$1.03M Buy
36,603
+3,351
+10% +$87.7K ﹤0.01% 3159
2018
Q4 		$813K Buy
33,252
+2,503
+8% +$67.3K ﹤0.01% 3224
2018
Q3 		$1.14M Buy
30,749
+8,161
+36% +$220K ﹤0.01% 3191
2018
Q2 		$469K Buy
22,588
+7,156
+46% +$126K ﹤0.01% 3659
2018
Q1 		$222K Hold
15,432
– – ﹤0.01% 3903
2017
Q4 		$234K Hold
15,432
– – ﹤0.01% 3883
2017
Q3 		$148K Hold
15,432
– – ﹤0.01% 3931
2017
Q2 		$133K Sell
15,432
-8,229
-35% -$70.2K ﹤0.01% 3974
2017
Q1 		$210K Sell
23,661
-9,433
-29% -$87.5K ﹤0.01% 3866
2016
Q4 		$367K Buy
33,094
+3,257
+11% +$35.1K ﹤0.01% 3711
2016
Q3 		$507K Buy
29,837
+7,772
+35% +$144K ﹤0.01% 3528
2016
Q2 		$480K Buy
22,065
+6,626
+43% +$119K ﹤0.01% 3560
2016
Q1 		$296K Buy
15,439
+5,705
+59% +$109K ﹤0.01% 3649
2015
Q4 		$272K Buy
9,734
+932
+11% +$26.4K ﹤0.01% 3769
2015
Q3 		$214K Buy
+8,802
New +$211K ﹤0.01% 3880

Other funds holding IRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
SI
Shaker Investments Cleveland, Ohio $278M AUM 69.83% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
BCC
Bridge City Capital Lake Oswego, Oregon $438M AUM 64.84% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Bank of New York Mellon's IRMD Position: Q2 2026 in Review

Bank of New York Mellon reduced its iRadimed (IRMD) stake by 5% in Q2 2026, selling an estimated $364K and leaving 75,885 shares worth $7.25M. The position accounts for ﹤0.01% of the portfolio, ranked #2208.

Bank of New York Mellon first reported a position in IRMD in Q3 2015 and has held it in 44 quarters since. The position peaked at $8.32M in Q4 2025. 98 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

  • Bank of New York Mellon held 75,885 shares of iRadimed worth $7.25M as of Q2 2026.
  • Bank of New York Mellon sold 3,992 iRadimed shares in Q2 2026, an estimated $364K.
  • iRadimed made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #2208 holding.
  • Bank of New York Mellon first reported a position in iRadimed in Q3 2015 and has held it in 44 quarters since.
  • Bank of New York Mellon's iRadimed position peaked at $8.32M in Q4 2025.
  • 98 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.